Drug name - Vivlodex

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9526734 ZYLA Formulation of meloxicam Mar, 2033

(10 years from now)

US9808468 ZYLA Formulation of meloxicam Mar, 2035

(12 years from now)

US9649318 ZYLA Formulation of meloxicam Mar, 2035

(12 years from now)

Drugs and Companies using MELOXICAM ingredient

Treatment: Management of osteoarthritis pain by administering 10 mg of meloxicam; management of osteoarthritis pain by administering 5 mg of meloxicam

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
5MG CAPSULE;ORAL Discontinued
10MG CAPSULE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.